Načítá se...
Anti-Vascular Endothelial Growth Factor Treatment for Proliferative Macular Telangiectasia Type 2
Idiopathic macular telangiectasia type 2 (IMT 2), is the most common type of a heterogeneous group of disorders, characterized by telangiectatic alterations of the juxtafoveolar capillary network. Vision loss is due to retinal atrophy and subretinal neovascularization (SRN). Here, we report the outc...
Uloženo v:
| Vydáno v: | Middle East Afr J Ophthalmol |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Medknow Publications & Media Pvt Ltd
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4845624/ https://ncbi.nlm.nih.gov/pubmed/27162458 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/0974-9233.171773 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|